Immunologic characterization of TAT72-transgenic mice: Effects of morphine on cell-mediated immunity
- 31 December 1994
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 16 (12) , 1061-1070
- https://doi.org/10.1016/0192-0561(94)90086-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Chronic Morphine Treatment Suppresses CTL-Mediated Cytolysis, Granulation, and cAMP Responses to AlloantigenBrain, Behavior, and Immunity, 1994
- Central α-adrenergic involvement in morphine-mediated suppression of splenic natural killer activityJournal of Neuroimmunology, 1994
- A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin.The Journal of cell biology, 1993
- Suppression of interleukin-2 and interleukin-2 receptor expression in jurkat cells stably expressing the human immunodeficiency virus tat proteinCellular Immunology, 1992
- New human gene encoding a positive modulator of HIV Tat-mediated transactivationNature, 1992
- HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.Genes & Development, 1992
- Memory B and T CellsAnnual Review of Immunology, 1991
- Morphine-induced immune alterations in vivoCellular Immunology, 1990
- Inhibition of Antigen-Induced Lymphocyte Proliferation by Tat Protein from HIV-1Science, 1989
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988